✦ LIBER ✦

A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer – GABG-IV B-93

✍ Scribed by Manfred Kaufmann; Erika Graf; Walter Jonat; Wolfgang Eiermann; Sabine Vescia; Matthias Geberth; Bettina Conrad; Günther Gademann; Ute-Susann Albert; Sibylle Loibl; Gunter von Minckwitz; Martin Schumacher

Book ID: 116429444
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 241 KB
Volume: 43
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2007.08.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CMF versus goserelin as adjuvant therapy

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: A randomised trial (GABG trial IV-A-93)

✍ Gunter von Minckwitz; Erika Graf; Matthias Geberth; Wolfgang Eiermann; Walter Jo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Dose-intensified epirubicin versus stand

Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group

✍ Wolfgang Eiermann; Erika Graf; Beyhan Ataseven; Bettina Conrad; Jörn Hilfrich; H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 665 KB

Prognostic impact of amenorrhoea after a

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI

✍ O. Pagani; A. O’Neill; M. Castiglione; R.D. Gelber; A. Goldhirsch; C.-M. Rudenst 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Treatment with trastuzumab for 1 year af

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

✍ Luca Gianni; Urania Dafni; Richard D Gelber; Evandro Azambuja; Susanne Muehlbaue 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 322 KB